Category - Developments

Developments

Biovica expands services with major TKa testing order

Biovica International (STO:BIOVIC-B; STO:BIOVIC.B; FRA:911) has announced the signing of a significant work order for TKa testing services, valued at 2.3 MSEK. The agreement has been made with a UK-based...

January 13, 2025

Developments

Arrivo unveils positive study results on SP-624’s impact on depression and cognition

Closely held Arrivo BioVentures has announced promising results from its study evaluating SP-624’s novel epigenetic mechanism of action on neurological pathways. According to the company, the findings provide insights...

January 10, 2025

Developments

FDA grants additional FTD to Mersana’s XMT-1660 for breast cancer

Mersana Therapeutics (NASDAQ:MRSN) has announced that the FDA has granted an additional fast track designation (FTD) to its emiltatug ledadotin (XMT-1660) for the treatment of advanced or metastatic breast cancer. The...

January 10, 2025

Developments

Genenta strengthens pact with CDMO to enhance production

Genenta Science (NASDAQ:GNTA) announced that it has amended its development and master services agreement with contract development and manufacturing organization (CDMO) AGC Biologics to bolster production capabilities...

January 10, 2025

Developments

Inspira responds to China’s recent hMPV outbreak; prepares to ramp up production

Inspira Technologies (NASDAQ:IINN) has announced its preparations for a possible increase in production of its INSPIRA ART100 device to address the growing demand for advanced respiratory care technologies following the...

January 10, 2025

Developments

Onco-Innovations’ technology aims to transform cancer treatments

Onco-Innovations (CSE:ONCO; FRANKFURT:W1H; WKN:A3EKSZ) has announced that its exclusively-licensed, patented polynucleotide kinase 3’-phosphates (PNKP) inhibitors technology holds the potential to significantly enhance...

January 9, 2025

Developments

MOBILion spotlights 100th peer-reviewed publication featuring its separations technology platform

Closely held MOBILion Systems has announced that, as of December 24, 2024, its foundational Structures for Lossless Ion Manipulation (SLIM) platform technology has been highlighted in 100 peer-reviewed publications in...

January 8, 2025

Developments

MediPharm expands Brazilian presence through agreement with Teuto

MediPharm Labs (TSX:LABS; OTCQX:MEDIF) has announced an agreement with Laboratório Teuto to expand its reach into the Brazilian medical cannabis market. The company states that it has been working closely with Teuto on...

January 8, 2025

Developments

FDA clears Solid’s IND application for SGT-212 in FA

Solid Biosciences (NASDAQ:SLBD) announced that the FDA has cleared its IND application for SGT-212, a first-in-industry dual-route of administration gene therapy designed to treat the neurologic and cardiac...

January 8, 2025

Developments

CytoMed and SunAct sign agreement for solid tumor treatment trial in India

CytoMed Therapeutics (NASDAQ:GDTC) has announced the signing of a five-year business and research collaboration agreement with the SunAct Cancer Institute to investigate the efficacy, safety, tolerability, and potency...

January 7, 2025

Category - Developments

Biovica expands services with major TKa testing order

Arrivo unveils positive study results on SP-624’s impact on depression and cognition

FDA grants additional FTD to Mersana’s XMT-1660 for breast cancer

Genenta strengthens pact with CDMO to enhance production

Inspira responds to China’s recent hMPV outbreak; prepares to ramp up production

Onco-Innovations’ technology aims to transform cancer treatments

MOBILion spotlights 100th peer-reviewed publication featuring its separations technology platform

MediPharm expands Brazilian presence through agreement with Teuto

FDA clears Solid’s IND application for SGT-212 in FA

CytoMed and SunAct sign agreement for solid tumor treatment trial in India

General

More